Inventage Lab

Inventage Lab Market Cap per Employee

The Market Cap per Employee of Inventage Lab (389470.KQ) as of Oct 23, 2026 is 16.88 B KRW. In the previous year, Market Cap per Employee was 16.88 B KRW — a change of 0.00% (lower).

Market Cap per Employee

16.88 BKRW

YoY

0.00%

Last updated:

Market Cap per Employee of Inventage Lab is 2025 16.88 B KRW. Market Cap per Employee of Inventage Lab was 2024 16.88 B KRW. It decreases by 0.00% lower compared to the previous year.

The Inventage Lab Market Cap per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market Cap per Employee
Date
Market Cap per Employee
Jan 1, 2019
16.88 B KRW
Jan 1, 2020
16.88 B KRW
Jan 1, 2021
16.88 B KRW
Jan 1, 2022
16.88 B KRW
Jan 1, 2023
16.88 B KRW
Jan 1, 2024
16.88 B KRW
Jan 1, 2025
16.88 B KRW
The Inventage Lab Market Cap per Employee history
YEARMarket Cap per EmployeeYoY
16.88 BKRW0.00%
16.88 BKRW0.00%
16.88 BKRW0.00%
16.88 BKRW0.00%
16.88 BKRW0.00%
16.88 BKRW0.00%
16.88 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inventage Lab Stock analysis

What does Inventage Lab do? Inventage Lab, Inc. generates revenue through the research, manufacture, and sale of human medicines targeting male pattern baldness, dementia, and prostate cancer, as well as veterinary medicines including combination drugs and chemical castration agents. The company leverages its proprietary platforms for long-acting injections and genetic material drug delivery to develop and scale production of these products. Its human medicine segment focuses on therapeutic areas with significant market demand, while veterinary medicines serve agricultural and companion animal markets. The firm's business model centers on proprietary technology platforms applied to both human and veterinary pharmaceutical development. These platforms enable the company to create and mass-produce innovative drug delivery systems, which are critical for the efficacy of their medicine portfolios. Revenue streams are derived from direct sales of these medicines to healthcare providers and veterinary institutions within their target markets. Inventage Lab, Inc. operates with a dual focus on human and veterinary pharmaceuticals, utilizing its specialized platforms to address unmet medical needs in both sectors. The company's product range includes treatments for specific conditions like male pattern baldness and prostate cancer, alongside veterinary applications such as chemical castration agents, which are sold to relevant industry stakeholders in their respective markets. Inventage Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inventage Lab stock

Market Cap per Employee of Inventage Lab is 16.88 B KRW in 2025.

Market Cap per Employee of Inventage Lab changed from 16.88 B KRW to 16.88 B KRW, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Market Cap per Employee Inventage Lab since 2006 – with annual values, charts, and detailed analysis.

Market cap per employee shows the market value attributed to each employee. Technology companies typically have higher values due to intellectual capital.

Market Cap per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Market Cap per Employee's Inventage Lab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Inventage Lab

All Key Metrics — Inventage Lab